Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production

Stem Cells

Volumn 26, Issue 11, 2008, Pages 2843-2854

  Piccoli, Claudia ^a   Scrima, Rosella ^a   Ripoli, Maria ^a   Ianni, Mauro D I ^b   Del Papa, Beatrice ^c   D'Aprile, Annamaria ^a   Quarato, Giovanni ^a   Martelli, Maria Paola ^c   Servillo, Giuseppe ^c   Ligas, Claudio ^b   Boffoli, Domenico ^a   Tabilio, Antonio ^b   Capitanio, Nazzareno ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

cAMP; Complex I; Mesenchymal stromal stem cell; Mitochondria; Reactive oxygen species; Retroviral vector

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 7; LENTIVIRUS VECTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ARTICLE; BONE MARROW CELL; CELL TRANSFORMATION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; GENETIC ENGINEERING; GENETIC TRANSFECTION; HOST CELL; HUMAN; HUMAN CELL; MARKER GENE; MESENCHYMAL STEM CELL; MITOCHONDRION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RESPIRATORY CHAIN; STROMA CELL;

BONE MARROW CELLS; CELL LINE; CELL RESPIRATION; CELL TRANSFORMATION, VIRAL; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ELECTRON TRANSPORT COMPLEX I; HUMANS; INTERLEUKIN-7; LENTIVIRUS; MESODERM; MITOCHONDRIA; MOLONEY MURINE LEUKEMIA VIRUS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; STROMAL CELLS; TRANSDUCTION, GENETIC;

EID: 56249133026     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0885     Document Type: Article

References (65)

1. Bianco P, Robey PG. Stem cells in tissue engineering. Nature 2001;414:118-121.
2. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003;4:346-358.
3. Nienhuis AW. Development of gene therapy for blood disorders. Blood 2008;111:4431-4444.
4. Laufs S, Gentner B, Nagy KZ et al. Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. Blood 2003;101:2191-2198.
5. Baum C, Dullmann J, Zhixiong L et al. Side effect of retroviral gene transfer into hematopoietic stem cells. Blood 2003;101:2099-2114.
6. Kustikova OS, Geiger H, Li Z et al. Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways. Blood 2007;109:1897-1907.
7. Cattoglio C, Facchini G, Sartori D et al. Hot spots of retroviral integration in human CD34+ hematopoietic cells. Blood 2007;110:1770-1778.
8. Hacein-Bey-Abina S, Von Kalle C, Schmidt M et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCIDX1. Science 2003;302:415-419.
9. Check E. Gene therapy put on hold as third child develops cancer. Nature 2005;433:561.
10. Nienhuis AW, Dunbar CE, Sorrentino BP et al. Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther 2006;13:1031-1049.
11. Bauer G, Dao MA, Case SS et al. In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. Mol Ther 2008;16:1308-1315.
12. Väänäanen HK. Mesenchymal stem cells. Ann Med 2005;37:469-479.
13. Satija NK, Gurudutta GU, Sharma S et al. Mesenchymal stem cells: Molecular targets for tissue engineering. Stem Cells Dev 2007;16:7-23.
14. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: Characteristics and clinical applications. Folia Histochem Cytobiol 2006;44:215-230.
15. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007;211:27-35.
16. Reiser J, Zhang XY, Hemenway CS et al. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 2005;5:1571-1584.
17. Fry TJ, Mackall CL. The many faces of IL-7: From lymphopoiesis to peripheral T-cell maintenance. J Immunol 2005;174:6571-6576.
18. Di Ianni M, Del Papa B, De Ioanni M et al. Mesenchymal cells: A vehicle for gene therapy. Blood Cells Mol Dis 2004;33:267-270.
19. Sportoletti P, Del Papa B, De Ioanni M et al. Interleukin-7-engineered mesenchymal cells: In vitro effects on naive T-cell population. Biol Blood Marrow Transplant 2006;12:1250-1260.
20. Di Ianni M, Papa BD, De Ioanni M et al. Interleukin 7-engineered stromal cells: A new approach for hastening naive T cell recruitment. Hum Gene Ther 2005;16:752-764.
21. Wu BW, Lu J, Gallaher TK et al. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide. Virology 2000;269:7-17.
22. Grignani F, Kinsella T, Mencarelli A et al. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res 1998;58:14-19.
23. Di Ianni M, Casciari C, Ciurnelli R et al. β-Galactosidase transduced T lymphocytes: A comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction. Haematologica 1996;81:410-417.
24. Cilloni D, Carlo-Stella C, Falzetti F et al. Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood 2000;96:3637-3643.
25. Chen C, Okayama H. High efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987;7:2747-2752.
26. Piccoli C, D'Aprile A, Ripoli M et al. Bone-marrow derived hematopoietic stem/progenitor cells express multiple isoforms of NADPH oxidase and produce constitutively reactive oxygen species. Biochem Biophys Res Commun 2007;353:965-972.
27. Margineantu DH, Gregory Cox W, Sundell L et al. Cell cycle dependent morphology changes and associated mitochondrial DNA redistribution in mitochondria of human cell lines. Mitochondrion 2002;1:425-435.
28. Villani G, Greco M, Papa S et al. Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types. J Biol Chem 1998;273:31829-31836.
29. Piccoli C, Scrima R, Boffoli D et al. Control by cytochrome c oxidase of the cellular oxidative phosphorylation system depends on the mitochondrial energy state. Biochem J 2006;396:573-583.
30. Adam-Vizi V, Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 2006;27:639-645.
31. Mukhopadhyay P, Rajesh M, Yoshihiro K et al. Simple quantitative detection of mitochondrial superoxide production in live cells. Biochem Biophys Res Commun 2007;358:203-208.
32. St-Pierre J, Drori S, Uldry M et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006;127:397-408.
33. Bellomo F, Piccoli C, Cocco T et al. Regulation by the cAMP cascade of oxygen free radical balance in mammalian cells. Antioxid Redox Signal 2006;8:495-502.
34. Piccoli C, Scacco S, Bellomo F et al. cAMP controls oxygen metabolism in mammalian cells. FEBS Lett 2006;580:4539-4543.
35. Gibson BW. The human mitochondrial proteome: Oxidative stress, protein modifications and oxidative phosphorylation. Int J Biochem Cell Biol 2005;37:927-934.
36. Palmisano G, Sardanelli AM, Signorile A et al. The phosphorylation pattern of bovine heart complex I subunits. Proteomics 2007;7:1575-1583.
37. Brandt U. Energy converting NADH:quinone oxidoreductase (complex I). Annu Rev Biochem 2006;75:69-92.
38. Grigorieff N. Structure of the respiratory NADH:ubiquinone oxidoreductase (complex I). Curr Opin Struct Biol 1999;9:476-483.
39. Genova ML, Ventura B, Giuliano G et al. The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2. FEBS Lett 2001;505:364-368.
40. Kussmaul L, Hirst J. The mechanism of superoxide production by NADH: Ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc Natl Acad Sci U S A 2006;103:7607-7612.
41. Ohnishi ST, Ohnishi T, Muranaka S et al. A possible site of superoxide generation in the complex I segment of rat heart mitochondria. J Bioenerg Biomembr 2005;37:1-15.
42. Fruehauf JP, Meyskens FL Jr. Reactive oxygen species: A breath of life or death? Clin Cancer Res 2007;13:789-794.
43. Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004;337:1-13.
44. Iiyama M, Kakihana K, Kurosu T et al. Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression. Cell Signal 2006;18:174-182.
45. D'Autréaux B, Toledano MB. ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007;8:813-824.
46. Scacco S, Vergari R, Scarpulla RC et al. cAMP-dependent phosphorylation of the nuclear encoded 18-kDa (IP) subunit of respiratory complex I and activation of the complex in serum-starved mouse fibroblast cultures. J Biol Chem 2000;275:17578-17582.
47. Technikova-Dobrova Z, Sardanelli AM, Speranza F et al. Cyclic adenosine monophosphate-dependent phosphorylation of mammalian mitochondrial proteins: Enzyme and substrate characterization and functional role. Biochemistry 2001;40:13941-13947.
48. Signorile A, Sardanelli AM, Nuzzi R et al. Serine (threonine) phosphatase(s) acting on cAMP-dependent phosphoproteins in mammalian mitochondria. FEBS Lett 2002;512:91-94.
49. Kustikova OS, Wahlers A, Kuhlcke K et al. Dose finding with retroviral vectors: Correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood 2003;102:3934-3637.
50. Wright GD, Thompson PR. Aminoglycoside phosphotransferases: Proteins, structure, and mechanism. Front Biosci 1999;4:D9-D21.
51. Eustice DC, Wilhelm JM. Fidelity of the eukaryotic codon-anticodon interaction: Interference by aminoglycoside antibiotics. Biochemistry 1984;23:1462-1467.
52. Nathans D. Puromycin inhibition of protein synthesis: Incorporation of puromycin into peptide chains. Proc Natl Acad Sci U S A 1964;51:585-592.
53. Dalhoff A. Pleiotropic actions of aminoglycosides. Antibiot Chemother 1987;39:182-204.
54. Shiraishi F, Visner GA, Nick HS et al. Geneticin induces endogenous heme oxygenase-1 expression: Implication in transfection studies. Anal Biochem 2001 Feb 15;289:303-305.
55. Hoppe G, Chai YC, Sears J. Endogenous oxidoreductase expression is induced by aminoglycosides. Arch Biochem Biophys 2003;414:19-23.
56. Jin QH, Zhao B, Zhang XJ. Cytochrome c release and endoplasmic reticulum stress are involved in caspase-dependent apoptosis induced by G418. Cell Mol Life Sci 2004;61:1816-1825.
57. Edwards SA, Adamson ED. Isolation of a clone of F9 teratocarcinoma cells "naturally" resistant to G418. J Cell Physiol 1987;133:46-54.
58. Rincon J, Romero M, Viera N et al. Increased oxidative stress and apoptosis in acute puromycin aminonucleoside nephrosis. Int J Exp Pathol 2004;85:25-33.
59. Marshall CB, Pippin JW, Krofft RD et al. Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo. Kidney Int 2006;70:1962-1973.
60. Su LH, Lee GA, Huang YC et al. Neomycin and puromycin affect gene expression in Giardia lamblia stable transfection. Mol Biochem Parasitol 2007;156:124-135.
61. Daigle DM, McKay GA, Thompson PR et al. Aminoglycoside antibiotic phosphotransferases are also serine protein kinases. Chem Biol 1999;6:11-18.
62. Bian JS, Zhang WM, Pei JM et al. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart. J Pharmacol Exp Ther 2000;292:1065-1070.
63. Lai HL, Yang TH, Messing RO et al. Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response. J Biol Chem 1997;272:4970-4977.
64. Schulkes CC, Verkerke-van Wijk I, Schaap P. Transformation with vectors harboring the NEOR selection marker induces germination-specific adenylylcyclase activity in Dictyostelium cells. Exp Cell Res 1995;220:505-508.
65. Aguiari P, Leo S, Zavan B et al. High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci U S A 2008;105:1226-1231.